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Abstract.  During the previous cloning of the fibrillin 
gene (FBN1), we isolated a partial eDNA coding for a 
fibrillin-like peptide and mapped the corresponding 
gene (FBN2) to human chromosome 5.  (Lee, B., M. 
Godfrey, E. Vitale, H.  Hori, M. G. Mattei, M. 
Sarfarazi, P.  Tsipouras, E  Ramirez, and D. W.  Hol- 
lister.  1991.  Nature  [Lond.].  352:330-334).  The study 
left, however, unresolved whether or not the FBN2 
gene product is an extracellular component structur- 
ally related to fibrillin. Work presented in this report 
clarifies this important point.  Determination of the en- 
tire primary structure of the FBN2 gene product 
demonstrated that this polypeptide is highly homolo- 
gous to fibrillin. Immunoelectron microscopy localized 
both fibrillin proteins to elastin-associated extracellular 
mierofibrils. Finally, immunohistochemistry revealed 
that the fibrillins co-distribute in elastic and non- 
elastic connective tissues of the developing embryo, 
with preferential accumulation of the FBN2 gene prod- 
uct in elastic fiber-rich matrices.  These results support 
the original hypothesis that the fibriUins may have dis- 
tinct but related functions in the formation and main- 
tenance of extracellular microfibrils. Accordingly, we 
propose to classify the FBN1  and FBN2 gene products 
as a  new family of extracellular proteins and to name 
its members fibrillin-1 and fibrillin-2, respectively. 
I 
T is now well established that fibriUin is the defective 
gene product responsible for the ophthalmic, cardio- 
vascular,  and  skeletal  manifestations of the  Marfan 
syndrome (MFS) ~ (Dietz et al.,  1991, 1992a,b,  1993a,b; 
Kainulainen et al., 1992; Hewett et al., 1993). FibriUin was 
originally isolated from the medium of cultured fibroblasts 
using an  antibody raised  against pepsin-treated  and salt- 
precipitated  proteins  from human  amnion  (Sakai  et  al., 
1986).  Biochemical analyses estimated fibrillin to be a 350- 
kD  acidic  glycoprotein with  a  large  number  of cysteine 
residues  (Sakai  et  al.,  1991). Additionally, fibrillin  was 
shown to be an integral component of the non-collagenous 
microfibrils with an average diameter of 10 nm (Sakai et al., 
1986,  1991). These extracellular aggregates are present in 
both elastic and non-elastic tissues (Low, 1962; Cleary and 
Gibson, 1983;  Mecham and Heuser, 1991). Microfibrils of 
elastic tissues have been shown to assemble into a scaffold 
upon which elastin is subsequently deposited, whereas in 
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non-elastic tissues they are believed to serve an anchoring 
function (for reviews see Mecham and Heuser, 1991; Rami- 
rez et al.,  1993).  Relevant to MFS pathology, microfibrils 
are a  major structural component of the suspensory liga- 
ments of the eye, the aortic wall, and the perichondrium and 
periosteum  (Mecham and Heuser,  1991; Ramirez et al., 
1993). 
Cloning experiments have established that the primary 
structure of fibrillin consists mainly of repeats similar to the 
calcium-binding (CB)  sub-class of the EGF motif (Maslen 
et al.,  1991; Lee et al.,  1991; Corson et al.,  1993;  Pereira 
et al., 1993).  These experiments identified a partial eDNA 
potentially coding for a fibriUin-like peptide, thus suggesting 
that fibrillin may represent a novel gene family (Lee et al., 
1991). The gene coding for this putative fibrillin-like tran- 
script was mapped to human chromosome 5. Based on their 
respective  chromosomal locations,  the  two  fibrillin tran- 
scripts were provisionally termed Fib 15 and Fib 5 and the 
corresponding genes FBN1 and FBN2 (Lee et al., 1991). In- 
terestingly, the latter was genetically linked to the MFS-like 
condition,  congenital contractural  arachnodactyly (CCA) 
(Lee et al., 1991; Tsipouras et al.,  1992).  Patients affected 
by this rare connective tissue disorder share some of the 
skeletal features of MFS, but display joint contractures in 
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from lacking the cardiovascular  and ocular manifestations of 
MFS, these patients exhibit characteristically misshaped ex- 
ternal ears (Be~s and Hecht,  1971). 
The association between phenotypically overlapping  con- 
ditiom and two potentially related macromolecules prompted 
us to suggest that Fib 5 and Fib 15 may have distinct but re- 
lated extracellular functions (Lee et al.,  1991).  This postu- 
late is supported by results presented in this  study  which 
demonstrates that Fib 5 is a microfibriUar constituent, whose 
structure and expression are related to those of Fib 15. Based 
on this evidence,  we propose to classify the fibrillins as a 
new family of extracellular proteins and to name its members 
fibrillin-1  (Fib  15) and fibrillin-2 (Fib 5). 
Materials and Methods 
Cloning Experiments and Northern Analysis 
A eDNA library in the phage vector larnbda-Zapll (Stratagene,  La Jolla, 
CA) was generated using as a template poly-A  + RNA purified from cul- 
tured MG-63 cells.  This human osteosareoma cell line was previously 
shown to produce significant amounts of fibrillin (Sakai et al., 1986). Gen- 
eration, screehing,  identification  and purification of recombinant phages 
were accompfished  by standard procedures (Sambrook et al.,  1989). The 
5' furthest eDNA was generated using the 5' RACE system for rapid am- 
plificatiun  of eDNA ends,  according to the manufacturer's  recommenda- 
tions (Life Technologies Inc., Gaithersbu~, MD). Positive eDNA inserts 
were sequenced  using the dideoxynucleotide  chain termination proo~ure 
on double-stranded DNA (Zagursky et al., 1986). Sequences were obtained 
by multiple sequencing of  both strands of eDNA inserts; they were  analyzed 
using the computer program MacVector  (International BioTechnologies, 
Inc., New Haven, CT). For Northern analysis,  '~10/~g of total RNA was 
fractionated on a 0.8% agarose gel in formamide/formaldehyde,  transferred 
onto a nylon membrane (Amersham Corp., Arlington Heights, IL), and hy- 
bridized at high stringency to fibrillin cDNA probes uniformly labeled by 
random priming (Sambrook et al.,  1989). To insure specificity, we chose 
as probes twv eDNA inserts of comparable size,  '~1 kb; they are: clone 
F-35, which covers the 3' non-coding region of the FBNI mRNA (Pcreim 
et al.,  1993), and the internal EcoRI insert of clone A06-13 (see Fig.  1). 
The latter sequence exhibits 40% homology to the equivalent region of the 
FBN1 gene, whereas there is only 6% homology in the untranslated seg- 
ment of the two transcripts. 
Antibody Generation 
Fibrillin antibodies were raised against recombinant peptides generated in 
the Escherichia  coli-based  expression system  pET-3xa  (Novagen,  Inc., 
Madison, WI). To this end, the sequences  coding for region C of the two 
fibrillins (see Fig. 3) were adapted to E. coli codon usage by ligating several 
overlapping synthetic oligonucleotides  prior to subcloning into the expres- 
sion vector (Sambrook et al.,  1989). Fusion products were expressed and 
isolated according to the manufacturer's  protocol. Approximately  1 nag of 
gel-purified fusion protein was injected subcutaneously into rabbits. The in- 
jection was repeated at 2-wk intervals for a total of 12 wk and serum was 
collected by ear vein puncture. Pre-immune sera were also collected from 
the same rabbits to test for specificity. 
Protein Analysis 
For metabolic labeling  experiments, MG-63 cells were cultured in cysteine- 
free and serum-free DME medium containing 60 pCi/rnl ]3SSlcysteine 
(Amersbam Corp.) (Sakai et al., 1986). After an overnight incubation, the 
culture medium was harvested and placed immediately on ice with the addi- 
tion of 5 mM EDTA, 50 pM N-ethylmaleimide,  and 50 ~tM phenyimethyl- 
sulfonyl  fluoride  (Sakai et al.,  1986).  Labeled cell cniture  medium was 
incubated with each unpurified fibrillin antibody coupled to protein A-Seph- 
arose for 3 h at 4°C. This was followed by extensive washing with PBS, and 
subsequently  with RIPA buffer  (150 mM NaCI,  1% NP-40, 0.5% DOC, 
0.1% SDS, and 50 mM Tris, pH 8.0). Bound material was eluted with gel 
electrophoresis  loading buffer (1% SDS, Tris 10 raM, pH 8, 5% glycerol, 
and 2.5 % B-mereaptcethanol)  and analyzed by fraetionation on a 4 % poly- 
acrylamide gel. For Western blot analysis,  unlabeled immunoprecipitates 
were  electrophoresed  onto  nitrocellulnse  paper  after gel  frnctionation 
(Harlow and Lane, 1988). The filter was blocked with 39[ BSA in 10 mM 
Tris, pH 8.0, 150 mM NaCI and 0.05% Tween-20, before incubation with 
each of the fibrillin antisera (Harlow and Lane, 1988). After bh incubation 
at room temperature the filter was washed, incubated for 30 rain with alka- 
line phospbatase-conjugated  anti-rabbit IgG (Promega Corp.,  Madison, 
WI),  washed  again,  and incubated with the substrate to  visualize the 
antibody-bound  electrophoretic  band  (Harlow  and  Lane,  1988).  Pre- 
immune serum was included as a negative control sample. 
Immunohistochemistry 
For indirect immunofluorescence  studies,  20-wk gestation human tissues 
were  immediately  frozen, sectioned, fixed in 4% paraformaldehyde  and 
processed  as previously described (Sakai et al.,  1986). Tissue specimens 
analyzed using the peroxidase  anti-peroxidase method were initially fixed 
in paraformaldehyde,  paraffin-embedded,  and processed further using a 
commercial kit with chromogen AEC as a substrate (Zymed Laboratories, 
Inc., San Francisco,  CA) following the manufacturer's recommendations. 
Tissue localization  of elastic fibers was accomplished  using standard Van 
Gieson elastic staining (Luna, 1968). All studies included preimmune se- 
rum as a negative control. 
Immunoelectron Microscopy 
Fetal bovine tissues were fixed in 4 % paraformaldehyde  in 0.1 M Sorensen's 
buffer (pH 7.4) for 4-6 h at 4°C and processed for reductive denaturation 
according to Gibson et al. (1989). 1issue specimens were dehydrated in a 
graded series of methanol to 90 % at progressively lower temperatures from 
4°C to -20°C. Samples were then infiltrated and embedded with Lowicryl 
K4M (SPI Supplies, West Chester, PA), which was subsequently polymer- 
ized by ultraviolet illumination for 24 h at -35°C and an additional 48 h 
at  -10°C.  Thin sections  of tissue were cut with a  diamond knife on a 
Reichcrt ultracut microtome and placed on formvar-coated nickel grids. Af- 
ter a 15-rain blocking step on drops of 1% BSA in 50 mM Tris containing 
100 mM NaC1 (pH 7.4), the grids were incubated with primary antibody 
diluted in blocking solution overnight at 4°C. Following extensive washing 
and a second blocking step, the grids were transferred to 15-pl drops of sec- 
ondary antibody for 1 h at room temperature.  The secondary antibody, goat 
F(AlY) 2 anti-rabbit IgG conjugated to 10 nm colloidal gold (BioCell Re- 
search Lab., Cardiff, UK), was used at a 1:30 dilution in blocking solution. 
Immunolabeled sections were counterstained with methanolic urmwl ace- 
tate for 2 min followed by lead cilrate for 30 s. Controls inchded the use 
of non-immunized rabbit serum and omission of primary antibody. 
Results 
Hbriilins Are Structurally Related Proteins 
We previously  reported the isolation  of MF-23,  a  partial 
cDNA that codes for a pcptide consisting mostly of EGF-CB 
repeats (Lee et al., 1991). The conceptual product of this 2.8- 
kb clone is remarkably  similar to the fibriMn protein origi- 
nally  identified by  Sakai  et all. (1986),  and  subsequently 
characterized  in  full  by  molecular  cloning  experiments 
(Maslen et al.,  1991; Lee et al.,  1991; Corson et al.,  1993; 
Pereira et al., 1993). To complete the characterization of Fib 
5, appropriate  sub-fragments  of MF-23 were used to screen 
the MG-63 cDNA library.  This and subsequent screenings 
led to the isolation of several  overlapping cDNAs covering 
the entire coding sequence of Fib 5 and almost 1.5 kb of 3' 
untranslated  sequence  (Fig.  1).  The experiments  also  re- 
vealed that the original MF-23 eDNA represents  the reverse 
transcribed  product of a partially  spliced transcript  with a 
long intronic sequence at its 3' end (Fig.  1). Overall, the Fib 
5 and Fib 15 sequences are highly homologous (Fig.  1); in 
addition, Northern analysis showed that the two proteins are 
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Figure L  Restriction map of 
fibrillin-2 cDNAs with a sche- 
matic illustration of the fibril- 
lind  and fibrillin-2 proteins. 
Letters indicate the five struc- 
turally distinct regions of the 
latter. Symbols designate the 
following  structural elements: 
EGF-like repeat (cross-hatched 
rectangle);  EGF-CB  repeat 
(white rectangle); TGF-bp re- 
peat (white oval);  Fib-motifs 
(other symbols). Note that re- 
gion C is depicted differently 
in the two fibrillins in order to 
emphasize  its  compositional 
diversity. A similar represen- 
tation of  the translational  prod- 
uct of the original clone MF- 
23 is also shown for compari- 
son; the dotted line indicates 
the unspliced intron sequence 
in MF-23. Letter on the cDNAs indicate the following restriction enzymes: Barn HI (B), Cla I (C), Eco RI (E) and Xho I (X). The open 
triangle and the pin-heads symbolize putative cell attaehmeat and glycosylation sites, respectively (see also Fig. 3). 
encoded by transcripts of similar size (Fig. 2). Based on this 
evidence, Fib  15 and Fib 5  were re-named fibrillin-1  and 
fibrillin-2, respectively. 
Fibrillin-1  is  a  multidomain  protein  consisting  of five 
structurally distinct regions termed A, B, C, D, and E (Fig. 
1) (Corson et al.,  1993; Pereira et al.,  1993). Although the 
precise start site of transcription remains to be determined, 
a  consensus has been reached on the putative start site of 
translation (Corson et al.,  1993). The predicted amino acid 
sequence of fibrillin-2 shows that this 2,889 amino acid poly- 
peptide can be divided into five regions analogous to do- 
mains A-E of fibrillin-1  (Fig.  1). 
Pairwise alignment of the fibrillins further emphasizes the 
close kinship between these two gene products (Fig.  3). In 
region D, for example, fibrillin-1  and fibrillin-2 contain 41 
EGF-CB repeats  similarly interspersed among eight non- 
EGF-CB motifs  (Fig.  1).  Both fibrillins exhibit the  same 
number of amino acids  between the cysteinyl residues  in 
nearly  all  of the  corresponding 49  pairs  of cysteine-rich 
repeats (Fig. 3). In addition, all but one of  the putative N-gly- 
Figure 2.  Northern  blot hy- 
bridization  of MG-63  RNA 
to  fibrillin-1  and  fibrillin-2 
probes. RNA size markers (in 
kb) are indicated on the left of 
the autoradiogram,  while the 
estimated  range  of the  two 
transcripts  is  shown on  the 
right. 
cosylation sites and the potential cell attachment sequence 
previously noted in fibrillin-1  (Maslen et al.,  1991) are con- 
served in fibrillin-2 (Fig.  3).  FibriUin-2 contains a  second 
RGD sequence within another non-EGF-CB repeat of region 
D (Fig. 3). The overall level of amino acid homology of re- 
gion D is •81%. 
Pairwise comparison of regions B, A, E, and C revealed 
several more similarities between fibrillin-1  and fibrillin-2, 
and at least one important difference. A  high level of se- 
quence homology (87%) was noted in region B of the two 
molecules. Region A, on the other hand, is substantially less 
homologous (19%) and it contains a novel proline-rich se- 
quence,  immediately  after  the  postulated  signal  peptide 
cleavage site (Fig. 3). The significance of this finding, if any, 
is unclear at present. Despite the compositional difference, 
region A of fibrillin-2 is as basic as region A  of fibriUin-1 
(est. pIs, 12 versus 11.1). Region E of fibrillin-2 displays also 
relatively low homology (50 %) to the corresponding domain 
of fibrillin-1.  In addition to two polylysine stretches at the 
carboxy terminus of region E, two cysteine residues found 
in this domain of fibriUin-1 are maintained in the same posi- 
tion in fibrillin-2 and in the context of a nearly identical se- 
quence (Fig. 3). Finally, region C  shows the most striking 
and  important  sequence divergence in  that this  short  se- 
quence  is  glycine  rich  in  fibrillin-2  but  proline  rich  in 
fibrillin-1. 
FibriUin-2 Is a MicrofibriUar Component 
The structural diversity of region C provided an experimen- 
tal means to characterize further the fibriUin  proteins. Ac- 
cordingly,  two  polyclonal antibodies  were  raised  against 
recombinant  peptides  of  region  C  from  fibrillin-1  and 
fibrillin-2 and used to immunoprecipitate radioactively la- 
beled proteins from the medium of cultured MG-63. 
Consistent with the cloning and Northern blot data, elec- 
trophoretic analysis of the immunoisolates revealed that the 
antibodies interact with proteins of similar size, about 350 
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Figure 3.  Comparison of the amino acid  sequences of fibrillin-1 
(top) and fibrillin-2 (bottom) with residues numbered according to 
Pereira et al. (1993). Identities and conservative changes are indi- 
cated by vertical bars, whereas one and two dots denote decreasing 
levels of evolutionary distance between amino acids calculated ac- 
cording to Gribskov and Burgess (1986).  Dashes were introduced 
for best alignment; the structural elements described in the text are 
underlined. The sequence of the glycine- and proline-rich regions 
used for the generation of the antibodies are italicized and the afore- 
mentioned residues are indicated in bold character.  Triangles  iden- 
Figure 4. (A) SDS-PAGE of radioactively labeled immunoisolates 
using anti-fibrillin-1  (Ab-flC)  or anti-fibrillin-2  (Ab-f2C)  antibod- 
ies. (B) unlabeled immunoprecipitates using anti-fibrillin-2 (lane 
1 ) or anti-fibriUin-1  (lane 2) antibodies immunoblotted against Ab- 
tiC.  Underneath  each lane is a silver staining of the gel showing 
equal loading of the two proteins. The estimated protein size is indi- 
cated on the fight side of each panel. The discrepancy in the relative 
mounts of fibrillin-2 mRNA (see Fig. 2) and protein, compared 
to fibrillin-1, might be due to differences in antibody affinities, epi- 
tope presentation, rate of mRNA translation  and/or protein secre- 
tion and stability. 
kD (Fig. 4 A). In addition, Western blot analysis of the im- 
munoisolates  documented  the  antibody  specificity  (Fig.  4 
B). To demonstrate that fibriUin-2 is actually associated with 
extracellular microfibrils, we used immunogold labeling at 
the ultrastrucmral  level. In this analysis, both the anti-fibril- 
lin-2  antibody  (Fig.  5  A) and the anti-fibdllin-1  antibody 
(Fig.  5  B)  were  specifically  localized  to  microfibrils as- 
sociated  with  elastic  fibers  in  fetal  bovine  ligamentum 
nuchae.  Similar specific localization of the antibodies was 
also observed on microfibrils of elastic laminae in fetal bo- 
vine aorta (data  not shown). 
1Issue Distribution of the FibriUin Proteins 
The fibrillin antibodies were then used to compare and con- 
trast the tissue distribution  of these macromolecules. As pre- 
viously shown by Sakai et al. (1986), we found that fibrillin-1 
staining in the skin involves the discrete filaments that extend 
from  the  dermis  to  the  epidermal  junction  (Fig.  6  A). 
Fibrillin-2 staining, on the other hand, was qualitatively,  if 
not quantitatively,  comparable to that of fibrillin-1,  and rela- 
tively higher in the periappendiceal dermis around hair folli- 
cles and sweat glands  (Fig.  6 B). 
Immunostalning  of fetal  aorta  and cartilaginous  tissues 
highlighted the enrichment of fibrillin-2 in elastic fiber-rich 
matrices. While the anti-fibrillin-1  antibody reacted with the 
tify  putative  signal  peptide  cleavage  sites;  asterisks indicate  the 
coding boundaries of MF-23;  and underlines highlight the struc- 
tural elements discussed in the text. The complete nucleotide se- 
quence of fibrillin-2 is available  from EMBL/C, enBank/DDJB un- 
der accession number U03272. 
The Journal of Cell Biology, Volume 124, 1994  858 Figure 5. Immunolocalization  of fibrillin-2 (,4) and fibrillin-1 (B) 
on a developing  elastic fiber in 170-d gestation bovine ligamentum 
nuchae. Gold particles label the peripheral mantle of microfibrils 
(MF) of the elastic fiber demonstrating the specific association of 
fibrillins with the microfibrils. Note that the central core of amor- 
phous elastin (E) is devoid of label. Bar, 0.2 ~m. 
connective tissue across all three layers of the fetal aorta 
(Fig.  7 A), staining with the anti-fibriUin-2 antibody was 
more intense in the media where elastic fibers are most abun- 
dant (Fig. 7 B). In elastic cartilage, fibrillin-1  staining was 
strong to moderate in the connective tissue adjacent to the 
central elastic cartilaginous core, but the core itself  remained 
urtreactive (Fig.  8 A).  In contrast,  this same core region 
stained strongly and evenly with the anti-fibrillin-2 antibody 
(Fig. 8 B). The same antibody also stained intensely the net- 
work of fibrils in the perichondrium directly adjoining the 
cartilage core (Fig. 8 B). In hyaline cartilage, fibriUin-1 epi- 
topes  were  distributed throughout the  cartilage  and  sur- 
rounding matrices (Fig. 8 C), while fibriUin-2 epitopes were 
mostly identified in the peripheral areas of the cartilage and 
in the perichondrium (Fig. 8 D). Interestingly, staining with 
the anti-fibrillin-1 antibody was somewhat augmented in the 
hypertrophic zone of the osteogenic cartilage where fibril- 
lin-2 was nearly undeteetable (Fig. 8, E  and F). 
In the cornea, fibrillin-2 expression was found to be more 
restricted than that of fibrillin-1, notably to the anterior third 
of  Descemet's membrane (Fig. 9, A and B). This morpholog- 
ically distinct portion of Descemet's membrane is organized 
in  a  characteristic  succession of banded  nodes  intercon- 
nected by strands and is known to be rich in type II collagen 
fibrils (von der Mark et al.,  1977;  Hendrix et al.,  1982). 
Fibrillin-1  was predominantly found in the outer layer and in- 
Figure 6.  Indirect immunofluorescence localization of fibrillins 
¢pitopes in human fetal skin using anti-fibrillin-1  (.4) and anti-fibril- 
lin-2 (B) antibodies. Bar, 100/~m. 
ner vascular choroid layer of the sclera, while fibrillin-2 was 
evenly distributed throughout (Fig. 9, D and E). A similar 
pattern of even, albeit low, fibrillin-2 distribution was ob- 
served in the lung where fibrillin-1 staining was significantly 
higher, particularly in the interlobular septa (Fig. 9, G and 
H). In contrast, the anti-fibrillin antibodies exhibited similar 
staining patterns in the basement membrane of  the glomeruli 
and in the developing collecting ducts of the fetal kidney 
(Fig. 9, J  and K). 
Discussion 
The term "rnicrofibrils" was originally used to identify mor- 
phologically similar matrix aggregates lacking the character- 
istic banding periodicity of interstitial collagen fibers (Low, 
1962).  This broad definition was subsequently narrowed to 
include only microfibrils with a diameter of 10 nm that may 
or may not be associated with elastic fibers (Cleary and Gib- 
son, 1983).  The complete inventory  of the macromolecular 
constituents of the microfibrils is presently unknown, chiefly 
because of the highly insoluble nature of these structures. 
Biochemical and immunochemical techniques have never- 
theless identified a number of distinct microfibrillar-associ- 
ated macromolecules (Gibson et al., 1989). Structural infor- 
mation about some of these microfibrillar components has 
Zhang et al.  Microfibrils Contain a  Second FibriUin Protein  859 The Journal of Cell Biology, Volume 124,  1994  860 Figure 8. Immunohistochemical localization of fibrillins in human fetal ear (A and B) and toe (C-F) using anti-fibrillin-1 (,4, C, and E) 
and anti-fibrillin-2  (B, D, and F) antibodies. In all panels the arrow highlights the perichondrium. On the other hand, the arrowhead points 
to the cartilaginous core in B, the peripheral areas of cartilage in D, and the hypertrophic zone in E.  Staining with pre-immtme serum 
was negative and localization of elastic fiber-containing areas was as for the analyses shown  in Fig. 5  (data not shown). Bar,  100 gm. 
Figure Z Immunohistochemical localization of fibrillins in human fetal aorta using anti-fibrillin-1 (,4) and anti-fibrillin-2 (C) antibodies. 
B and D show samples treated with preimmune serum and stained for elastic fibers, respectively. Note that the lumen of the aorta is always 
at the top left corner. Bar, 200/zm. 
Figure 9.  Immunolocalization of fibrillins in human fetal ocular tissues (A-F), lung ((7-/) and kidney (J-L) using anti-fibrillin-1 (,4, D, 
G, and J) and anti-fibrillin-2 (B, E, H, and K) antibodies. C, E  L  and L show samples treated with pre-immune serum. The arrowhead 
highlights the Descemet's membrane (A-C), the outer layer of the sclera (D-F), the inteflobular septa of the lung (G-l) and the glomeruli 
of the kidney (J-L). In A-C, the arrow points to the anterior portion of the cornea, in which stained necrotic debris are noticeable, and 
to the developing collecting ducts in J-L.  Bars: (A-C)  I0 gm; (D-L) 50/zm. 
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for the 31-kD microfibril-associated glycoprotein (MAGP), 
the 58-kD associated microfibril protein (AMP) and the 350- 
kD fibrillin (Gibson et al., 1991; Chert et al., 1993; Horrigan 
et al.,  1992; Maslen et al.,  1991; Lee et al.,  1991; Corson 
et al., 1993; Pereira et al.,  1993). Contrary to previous evi- 
dence, cloning of a partial transcript suggested that fibrillin 
may represent a small family of extracellular proteins (Lee 
et al.,  1991).  Results presented in this paper confirm and 
extend this observation;  in addition,  they provide the first 
comparison of the tissue distribution of the fibrillin family 
members. 
The sequencing data indicate that the structure of fibril- 
lin-2  replicates  very closely that  recently  established  for 
fibrillin-I  (Maslen et al.,  1991; Lee et al.,  1991; Corson et 
al.,  1993;  Pereira  et  al.,  1993).  As  a  result,  the  struc- 
tural/functional criteria defining a fibriUin molecule are be- 
ginning to emerge.  Accordingly, such a macromolecule is 
expected  to  be made  of five structurally  distinct  regions 
preceded by a short signal peptide. Two of these regions are 
composed of cysteine-rich sequences that can be segregated 
into three distinct groups.  The first and largest,  comprises 
numerous  EGF-CB  repeats  and  fewer  EGF-like  repeats 
(Davis, 1990). The second group features an 8-eysteine mo- 
tif which was first described interspersed among the EGF- 
like repeats of the TGF-/31-binding  protein, and is termed the 
TGF-bp motif (Kanzaki  et al.,  1990).  The third  class of 
fibrillin repeats is heterogeneous in composition and appar- 
ently unique to this protein (Corson et al.,  1993; Pereira et 
al., 1993). We have referred to these repeats as the Fib motifs 
and recently postulated their evolution from various rear- 
rangements of ancestral exons coding for EGF-like and TGF- 
bp repeats (Pereira et al., 1993). We based our evolutionary 
considerations  on structural  homologies and the organiza- 
tion of the coding sequence of the FBN1 gene, which prelim- 
inary evidence suggests to be similar in the FBN2 gene. 
In our previous work on fibrillin-1,  we suggested that re- 
gion C may be of some potential relevance to microfibril as- 
sembly (Pereira et al.,  1993). Based on its relative position 
and  composition,  we argued  that  region  C  may bend the 
fibril/in molecule and thus facilitate the postulated protein 
interactions  of the  cysteine-rich  regions  (Pereira  et  al., 
1993). Such a scenario needs not to be changed for fibril- 
lin-2, since the sequence of region C could theoretically form 
a poly-glycine hinge and thus provide the protein with a high 
degree of flexibility at that position (Claassen  and Gross- 
mann,  1991).  Region  E  is  also  of potential  relevance  to 
microfibril assembly, for it contains the same two cysteines 
already  noted  in  the  corresponding  segment of fibrillin-1 
(Maslin et al.,  1981). The maintenance of these residues in 
two different chains, together with the extensive identity of 
the sequence around them,  may conceivably indicate that 
they participate in the polymerization of individual fibriUin 
monomers. 
In general, the tissue distribution of fibrilfin-1  resembles 
that of fibrillin-2.  There are however some notable differ- 
ences which are likely to imply distinct functions of the two 
glycoproteins  in  the  assembly  and  maintenance  of  the 
microfibrillar  network.  The  most obvious of these differ- 
ences is the preferential localization of fibrillin-2 to extracel- 
lular matrices that are rich in elastic fibers. This feature is 
best exemplified in the elastic cartilage of the external ear. 
This preferential distribution of fibrillin-2 is also consistent 
with the abnormal presentation of the CCA auricle which is 
characterized by flattening of the helix and crumpled appear- 
ance of the antibelix with resulting partial obliteration of the 
concha (Beals and Hecht, 1971). Hyaline cartilage is another 
tissue that exhibits the intriguing feature of a differential dis- 
tribution of the two fibrillins, plausibly a reflection of distinct 
contributions of these proteins to the process of skeletogene- 
sis. Along this fine, it is of some interest to note the restricted 
localization of fibrillin-2 to the type II collagen-rich layer of 
Descemet's membrane. 
It is likely that the contribution of fibrillin-2 to tissue in- 
tegrity will be eventually clarified with the analysis of natu- 
rally occurring mutations in humans and artificially gener- 
ated ones in transgenic mice. Along these lines, the complete 
characterization of the FBN2 gene and the detailed examina- 
tion of its early developmental pattern of expression are both 
necessary preconditions to undertaking these investigations. 
From this and related work, it is becoming apparent that the 
function of the 10-nm microfibrils is likely to depend on the 
integrity and proper spatio-temporal  expression of several 
distinct  gene products.  More generally,  the microfibrillar 
aggregates with or without elastin cores are increasingly be- 
coming appreciated as critical players in providing biome- 
chanical properties to a wide variety of tissues and organ 
systems. 
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